Belenos Biosciences is a startup based in the United States, 1 tracked investor.
Belenos Biosciences is a company founded in 2024 headquartered in the United States. Brouky records 1 investor associated with the company.
Belenos Biosciences develops long-acting bispecific antibody therapeutics targeting key pathways in chronic inflammatory diseases such as asthma, COPD, and atopic dermatitis to provide durable and comprehensive control of immune and tissue-level inflammation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.